drugset / Trial / NCT02053519

Can Vitamin D Supplementation Improve Hepatitis C Cure Rates

NCT02053519

Phase 3 Completed 72 enrolled University of Dundee
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Evidence suggests that vitamin D may be directly or indirectly a co-factor for the efficacy of Hepatitis C virus, (HCV), antiviral therapies. The level of vitamin D necessary for optimum immune function is ill defined and many of those with HCV infection in Scotland are below these levels. Vitamin D is a cheap and safe medication, so its addition to anti-viral therapy should be highly cost-effective even if only a modest increase in SVR was achieved. Given the Scottish HCV epidemic, the world leading government response to it and the nationally low vitamin D levels, Scotland is perfectly placed to answer this question. Therefore the investigators hypothesize that vitamin D supplementation will improve SVR and propose a randomised controlled trial to test this hypothesis. The anticipated end of study date for this study is April 2015

Timeline

Start
2014-02
Primary completion
2016-04
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 100000 iu Oral